comparemela.com

Latest Breaking News On - Redkar hospital - Page 1 : comparemela.com

Herald: Balrath bus reduced to ashes at Dhargal

Goa News : Latest Goa News Updates from oHeraldo, Goa s Largest Circulated English News daily. Get all your Daily News Updates. Fearless Reporting. Subscribe to get the latest news in Goa

50-yr-old dies in wild boar attack at Pernem | Goa News

Panaji: On Sunday, a 50-year-old resident of Varkhand, Pernem, was allegedly killed in a wild boar attack in a forest area. Pernem PI Jivba Dalvi said Ankush Parab was brought dead on Sunday morning to Redkar Hospital in Dhargal. After receiving the information, police arrived at the hospital for investigations. Dalvi said that Parab and his brother had gone into a forest area in Varkhand around 9am to graze their cattle. “Suddenly, he was attacked by a wild boar. This caused a deep cut and bleeding injuries to his right leg hamstring and left hand bicep region. After the postmortem was conducted, his body was handed over to his relatives,” Dalvi said.

Bharat Biotech concludes recruitment for Covaxin s phase 3 study

Bharat Biotech concludes recruitment for Covaxin s phase 3 study ​ By Ashish Srivastava ( IANS) | Published on ​ Thu, Jan 7 2021 12:51 IST | ​ 0 Views Covaxin generated excellent safety data, says Bharat Biotech. Image Source: IANS News New Delhi, Jan 7 : Hyderabad-based vaccine manufacturer Bharat Biotech has concluded the recruitment of volunteers for the phase III trials of its Covid vaccine, Covaxin, on Thursday after achieving the sample size it had promised to the ethics committee. The firm has achieved the targeted number of volunteers, which is 25,800 participants, in total. The recruitment was supposed to be concluded by December 31 but was extended by a week since it was short of 4,000 volunteers that time.

Covaxin trial: Bharat Biotech completes recruitment for phase III study

Covaxin trial: Bharat Biotech completes recruitment for phase III study IANSJan 7, 2021, 13:05 IST BUSINESSINSIDER Bharat Biotech has concluded the recruitment of volunteers for the phase III trials of its Covid vaccine, Covaxin, on Thursday after achieving the sample size it had promised to the ethics committee. The firm has achieved the targeted number of volunteers, which is 25,800 participants, in total. The recruitment was supposed to be concluded by December 31 but was extended by a week since it was short of 4,000 volunteers that time. Dr. Sanjay Kumar Rai, head of community medicine and principal investigator of the trial at All India Institute of All

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.